Date published: 2026-5-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

Slp2 Inhibitors

SLP2 inhibitors refer to a class of chemical compounds that have been designed and studied for their capacity to modulate the activity or expression of SLP2 (Stomatin-Like Protein 2). SLP2, also known as STOML2 (Stomatin-Like Protein 2), is a membrane protein primarily found in the mitochondria and is known to play multifaceted roles in cellular processes, particularly those related to mitochondrial function, lipid metabolism, and cellular responses to stress. SLP2 is of particular interest to researchers because of its implication in mitochondrial homeostasis and its potential relevance to various cellular processes.

Inhibitors of SLP2 are chemical compounds designed to interact with SLP2 directly or indirectly, either by modulating its expression levels or influencing its cellular functions. These inhibitors can be small molecules or targeted agents that interfere with SLP2's interactions with other proteins, its subcellular localization, or its post-translational modifications. Researchers have been exploring these inhibitors to gain a better understanding of the precise roles that SLP2 plays in cellular physiology and to uncover potential links between SLP2 dysregulation and various diseases or conditions. By inhibiting SLP2, scientists aim to dissect the functional consequences of altered SLP2 activity, shedding light on its involvement in processes such as mitochondrial dynamics, lipid metabolism, and stress responses.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid (Vorinostat) may cause the acetylation of histone and non-histone proteins that are critical for maintaining the Slp2 gene in a transcriptionally repressed state, resulting in decreased Slp2 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

By inhibiting the JNK signaling pathway, SP600125 might suppress the activation of transcription factors that are required for the initiation of Slp2 gene transcription, thus inhibiting its expression.